Capital Research Global Investors
ELAN icon

Capital Research Global Investors’s Elanco Animal Health ELAN Stock Holding History

Capital Research Global Investors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-818,989
Closed -$28.6M – 419
2018
Q3 		$28.6M Buy
+818,989
New +$28.8M 0.01% 376

Other funds holding ELAN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors's ELAN Position: Q4 2018 in Review

Capital Research Global Investors sold out of Elanco Animal Health (ELAN) in Q4 2018, closing a stake of 818,989 shares — an estimated $28.6M sold.

Capital Research Global Investors first reported a position in ELAN in Q3 2018 and held it in 1 quarter. The position peaked at $28.6M in Q3 2018. 169 funds tracked by Wall St. Rank hold ELAN as of Q4 2018.

  • Capital Research Global Investors reported no remaining Elanco Animal Health position as of Q4 2018 after selling out during the quarter.
  • Capital Research Global Investors sold 818,989 Elanco Animal Health shares in Q4 2018, an estimated $28.6M.
  • Capital Research Global Investors first reported a position in Elanco Animal Health in Q3 2018 and held it in 1 quarter.
  • Capital Research Global Investors's Elanco Animal Health position peaked at $28.6M in Q3 2018.
  • 169 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2018.

Based on Capital Research Global Investors's 13F filing for Q4 2018, filed 14 Feb 2019.